HMG CoA PHARMACEUTICAL COMPOSITION AND THERAPEUTIC COMBINATION COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND HMG CoA REDUCTASE INHIBITORS

摘要

The present invention provides novel cholesteryl ester transfer protein (CETP) inhibitors and HMG CoA reductase inhibitors that can be used in the treatment of subjects suffering from or at increased risk for cardiovascular disease, particularly hyperlipidemia or complex dyslipidemia, To pharmaceutical compositions and therapeutic combinations comprising them.